Mass spectrometry and machine learning show promise for early cancer detection and prognosis by analyzing metabolic signatures.

Prioritize and focus resources on LNCB74 (B7-H4 ADC) with a planned IND submission by year-endCash of approximately $75 million expected to fund operations into second half of 2026 BELTSVILLE, Md., ...

Gujarat Biotechnology Research Centre (GBRC) has successfully transferred three innovative technologies to private firms, aiming to improve the identification and treatment of hereditary cancers and ...